MKO Minute – When Cures Become Commodities

MKO Minute – When Cures Become Commodities

The price wars in Hepatitis C continues as both Gilead and AbbVie launch their respective products into a market with a diminishing number of new patient starts. Which of the companies’ pricing strategies will prevail? Click HERE see full size image...Read more...